208 related articles for article (PubMed ID: 37016911)
21. Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
Bansal S; Boucher R; Shen J; Wei G; Chertow GM; Whelton PK; Cushman WC; Cheung AK; Beddhu S;
Clin J Am Soc Nephrol; 2024 May; 19(5):620-627. PubMed ID: 38262377
[TBL] [Abstract][Full Text] [Related]
22. Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics.
Tamargo J; Segura J; Ruilope LM
Expert Opin Pharmacother; 2014 Mar; 15(4):527-47. PubMed ID: 24444254
[TBL] [Abstract][Full Text] [Related]
23. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients?
Taber DJ; Srinivas TM; Pilch NA; Meadows HB; Fleming JN; McGillicuddy JW; Bratton CF; Thomas B; Chavin KD; Baliga PK; Egede LE
Am J Nephrol; 2013; 38(4):285-91. PubMed ID: 24061145
[TBL] [Abstract][Full Text] [Related]
24. Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents.
Tamargo J; Segura J; Ruilope LM
Expert Opin Pharmacother; 2014 Apr; 15(5):605-21. PubMed ID: 24456327
[TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of diuretics in treating hypertension.
Freis ED
Ann Intern Med; 1995 Feb; 122(3):223-6. PubMed ID: 7810942
[TBL] [Abstract][Full Text] [Related]
26. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
27. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
Melian EB; Jarvis B
Drugs; 2002; 62(5):787-816. PubMed ID: 11929332
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.
Peterzan MA; Hardy R; Chaturvedi N; Hughes AD
Hypertension; 2012 Jun; 59(6):1104-9. PubMed ID: 22547443
[TBL] [Abstract][Full Text] [Related]
29. Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.
Tully PJ; Hanon O; Cosh S; Tzourio C
J Hypertens; 2016 Jun; 34(6):1027-35. PubMed ID: 26886565
[TBL] [Abstract][Full Text] [Related]
30. Comparison of indapamide with thiazide diuretics in patients with essential hypertension.
Chalmers JP; Bune AJ; Graham JR; West MJ; Wing LM
Med J Aust; 1981 Jul; 2(2):100-1. PubMed ID: 7300705
[TBL] [Abstract][Full Text] [Related]
31. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.
Naci H; Salcher-Konrad M; Dias S; Blum MR; Sahoo SA; Nunan D; Ioannidis JPA
Br J Sports Med; 2019 Jul; 53(14):859-869. PubMed ID: 30563873
[TBL] [Abstract][Full Text] [Related]
32. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
[TBL] [Abstract][Full Text] [Related]
33. Diuretic-induced hypokalaemia: an updated review.
Lin Z; Wong LYF; Cheung BMY
Postgrad Med J; 2022 Jun; 98(1160):477-482. PubMed ID: 33688065
[TBL] [Abstract][Full Text] [Related]
34. Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension.
Wellington K; Faulds DM
Drugs; 2002; 62(13):1983-2005. PubMed ID: 12215069
[TBL] [Abstract][Full Text] [Related]
35. Use of diuretics and risk of incident gout: a population-based case-control study.
Bruderer S; Bodmer M; Jick SS; Meier CR
Arthritis Rheumatol; 2014 Jan; 66(1):185-96. PubMed ID: 24449584
[TBL] [Abstract][Full Text] [Related]
36. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of Patient Activation Interventions With or Without Financial Incentives to Promote Prescribing of Thiazides and Hypertension Control: A Randomized Clinical Trial.
Kaboli PJ; Howren MB; Ishani A; Carter B; Christensen AJ; Vander Weg MW
JAMA Netw Open; 2018 Dec; 1(8):e185017. PubMed ID: 30646291
[TBL] [Abstract][Full Text] [Related]
38. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
39. Association of Thiazide-Type Diuretics With Glycemic Changes in Hypertensive Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
Zhang X; Zhao Q
J Clin Hypertens (Greenwich); 2016 Apr; 18(4):342-51. PubMed ID: 26395424
[TBL] [Abstract][Full Text] [Related]
40. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]